improved glucose tolerance_Nos2<tm1Mrl>/Nos2<tm1Mrl>

http://metadb.riken.jp/0005292I129S7SvEvBrdC57BL6Nos2tm1MrlNos2tm1MrlNos2tm1Mrl

improved glucose tolerance_Nos2<tm1Mrl>/Nos2<tm1Mrl>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• nitric oxide synthase 2, inducible
  http://metadb.riken.jp/db/mgi_rdf/MGI:97361

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Nos2<tm1Mrl>/Nos2<tm1Mrl>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Nos2<tm1Mrl>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S7/SvEvBrd * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• improved glucose tolerance
  http://purl.obolibrary.org/obo/MP_0005292

文献

http://purl.org/net/cito/citesAsAuthority

• M. Perreault, et.al., Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle., Nature medicine, 2001, 7
  http://rdf.ncbi.nlm.nih.gov/pubmed/11590438